Products
BioEngine has developed nearly 100 types of serum-free media for different cell lines, which are suitable for antibodies, vaccines and cell and gene therapy (CGT) fields.
The BioEngine R&D team started the research in techniques for the culture of MDCK cells in 1995. Based on more than 10 years of technology accumulation and an AI-intelligent high-throughput data screening platform, BioEngine has released the Xeno series and SF003 MDCK serum-free media for MDCK cells.
Xeno series media are applicable for the rapid adaptation of MDCK cells, support high-density culture, and the high-efficiency proliferation of various flu virus subtypes. The series media have been applied in the CTA of human flu vaccines.
SF003 is suitable for the rapid adaptation of MDCK cells, supporting high-density culture, as well as the high-efficiency proliferation of avian influenza and swine influenza viruses, and has been applied in several industrial production projects.
Xeno series and SF003 serum-free medium for MDCK cells
Serum free
Animal-derived component-free
Protein free
Support rapid serum-free suspension adaptation of adherent MDCK cells
Support high-efficiency proliferation and high-density culture of MDCK cells
Xeno supports high-efficiency proliferation of the human flu virus
SF003 supports high-efficiency proliferation of avian influenza and swine influenza viruses
Xeno series MDCK Serum-Free Media
ADCF; TSE/BSE statement available on demand;
Distinctive culture results proven in numerous studies on human flu virus subtypes;
Optional powder media for use in large-scale manufacturing with easy preparation procedures;
Powder media capable of a single batch size of 100,000 L;
Excellent inter-batch consistency (CPK* > 1.33);
Full traceability by EU-certified ISO13485:2016 Quality Management System;
Complete documents in support of CTA for easier regulatory submission.
SF003 MDCK Serum-Free Media
Distinctive culture results proven in numerous studies on avian influenza virus subtypes;
Optional powder media for use in large-scale manufacturing with easy preparation procedures;
Powder media capable of a single batch size of 100,000 L;
Excellent inter-batch consistency (CPK* > 1.33);
Full traceability by EU-certified ISO13485:2016 Quality Management System. *CPK is a standard index to state the capability of one process. CPK>1.33: the process is capable and meets specification limits. The higher the CPK, the better.
We have a professional technical team to provide high quality one-stop cell culture service from process development
and optimization, medium formulation design to medium processing and manufacturing for all biopharmaceutical companies.
If you have any question, please click "Quick Message" and leave your message, we will reply to you as soon as possible.
If anything urgent, please call (86)21-68582660-2792.
3F&4F, Building 3, Lane 396, Lvzhou Ring Road, Minhang District, Shanghai, PRC